GlobalAccess Europe (ex-UK) Alpha Fund B Acc GBP (Hedged)Register to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 5.0 | 25.3 | -15.2 | 18.2 | 7.1 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 25/04/2024 | GBP 2.25 | |
Day Change | -1.10% | |
Morningstar Category™ | Other Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | IE00B5V4SJ08 | |
Fund Size (Mil) 28/03/2024 | EUR 102.53 | |
Share Class Size (Mil) 28/03/2024 | GBP 1.04 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 15/02/2024 | 1.74% |
Investment Objective: GlobalAccess Europe (ex-UK) Alpha Fund B Acc GBP (Hedged) |
The Fund seeks superior long-term capital growth primarily through investment in companies of European Countries, excluding the UK. The Fund is actively managed. The Fund invests primarily in common stock, preferred shares and securities convertible into common stock, of established companies domiciled or having significant operations (and listed or traded on a Regulated Market) in a range of European Countries, excluding the UK. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ian Aylward 01/03/2019 | ||
Inception Date 12/06/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for GlobalAccess Europe (ex-UK) Alpha Fund B Acc GBP (Hedged) | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.57 |
ASML Holding NV | Technology | 3.13 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.65 |
UniCredit SpA | Financial Services | 2.29 |
Sanofi SA | Healthcare | 2.18 |
Increase Decrease New since last portfolio | ||
GlobalAccess Europe (ex-UK) Alpha Fund B Acc GBP (Hedged) |